abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention relates to pharmaceutical industry and represents application of calix[6]arene of formula (1A) or (1B) for treatment of skin contamination with uranium, plutonium or americium. n EFFECT: invention ensures stability of calix[6]arenes with actinides in static mode. n 5 cl, 4 ex, 11 dwg |